Showing results (181-190 of 260) with videos related to
Sort By:
Pageof 26
Blood|April 15, 1990
Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disordersM S Currie, M Vala, D S Pisetsky, et al.Blood|June 1, 1982
Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinosideH J Weinstein, T W Griffin, J Feeney, et al.Blood|May 15, 1996
Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient miceF Arguello, J A Sterry, Y Z Zhao, et al.JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1983
Reversal of biochemical and functional abnormalities in erythrocytes secondary to selenium deficiencyS S Baker, W W King, L Michel, et al.JAMA|May 16, 1986
A randomized, controlled clinical trial of a geriatric consultation team. Compliance with recommendationsC M Allen, P M Becker, L J McVey, et al.Leukemia Research|January 1, 1990
Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trialR S Stein, W R Vogler, E F Winton, et al.Cancer|October 15, 1992
Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemiaS G Kreissman, R D Gelber, H J Cohen, et al.Journal of Leukocyte Biology|May 1, 1992
Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitorK M Rao, J Padmanabhan, D L Kilby, et al.International Journal of Cancer|November 11, 1992
Effect of IL-1 on experimental bone/bone-marrow metastasesF Arguello, R B Baggs, B T Graves, et al.The American Journal of Medicine|March 21, 2000
Calcium channel blockers and cancerH J Cohen, C F Pieper, J T Hanlon, et al.Pageof 26